Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 2:58 PM
Ignite Modification Date:
2025-12-25 @ 1:23 PM
NCT ID:
NCT03210259
Group ID:
EG000
Title:
Humira Containing All RTS Subjects (Run-In Period)
Description:
All patients received US-licensed Humira during the run-in period of 14 weeks (Period 1). Patients were administered with a loading dose of 80 milligram (mg) US-licensed Humira on Day 1 (Week 1), followed by 40 mg every other week from Week 2 to Week 12. Trial medication were administered by subcutaneous (s.c.) injection providing in single-use pre-filled syringes (PFS) containing 40 mg of adalimumab per 0.8 milliliter (mL).
All patients in the run-in period were in this group including those who were randomised and who did not being randomised after the run-in period.
Deaths Number Affected:
1
Deaths Number At Risk:
None
Serious Number Affected:
6
Serious Number At Risk:
259
Other Number Affected:
24
Other Number At Risk:
259
Study:
NCT03210259
Results Section:
NCT03210259
Adverse Events Module:
NCT03210259